Diabetes management necessitates innovative approaches to enhance treatment efficacy and patient adherence. The study aimed to develop a transdermal patch loaded with emodin, hypothesized to provide a noninvasive treatment option that circumvents complications of oral administration. To optimize the formulation, a full factorial experimental design was employed, focusing on the concentrations of hydroxypropyl methylcellulose K15 and geraniol. Compatibility and mechanical characteristics were investigated using Fourier-transform infrared spectroscopy and differential scanning calorimetry. The patch’s drug release profile was assessed via in vitro studies, while its stability was tested under accelerated conditions. The antidiabetic efficacy was evaluated in diabetic rats using an in vivo model. The optimized patch (batch SF7) released 94.57% of the drug over 12 h. Under accelerated stability conditions, the patch showed a minor decline in folding endurance from 396 ± 1.50 to 369 ± 2.63 folds and drug content uniformity from 98.70% ± 0.02% to 98.14% ± 0.23%. The in vivo antidiabetic study demonstrated a considerable decrease in blood glucose levels in SF7-treated rats from 245.83 ± 3.25 mg/dL to 120.86 ± 4.24 mg/dL over 12 h (p-value < 0.001), comparable with the standard drug glibenclamide. The emodin-loaded transdermal patch displayed consistent drug release, maintained stability, and demonstrated significant antidiabetic activity, suggesting that it is a promising noninvasive therapy for diabetes management.
MekalaKC, BertoniAG. Epidemiology of diabetes mellitus. In Transplantation, bioengineering, and regeneration of the endocrine pancreas. Academic Press; 2020. pp. 49–58, doi: 10.31083/j.rcm2512436
4.
SinghN, KesherwaniR, TiwariAK, et al.A review on diabetes mellitus. The Pharma Innovation, 2016; 5(7, Part A):36.
5.
UnnikrishnanR, AnjanaRM, MohanV. Diabetes mellitus and its complications in India. Nat Rev Endocrinol, 2016; 12(6):357–370; doi: 10.1038/nrendo.2016.53
6.
ZhengQ, LiS, LiX, et al.Advances in the study of emodin: An update on pharmacological properties and mechanistic basis. Chin Med, 2021; 16(1):102–124; doi: 10.1186/s13020-021-00509-z
7.
EidSA, AdamsM, SchererT, et al.Emodin, a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents. Eur J Pharmacol, 2017; 798:77–84; doi: 10.1016/j.ejphar.2017.01.022
8.
XueJ, DingW, LiuY. Anti-diabetic effects of emodin involved in the activation of PPARγ on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice. Fitoterapia, 2010; 81(3):173–177; doi: 10.1016/j.fitote.2009.08.020
9.
DongX, FuJ, YinX, et al.; Huyiligeqi. Emodin: A review of its pharmacology, toxicity and pharmacokinetics. Phytother Res, 2016; 30(8):1207–1218; doi: 10.1002/ptr.5631
10.
MartorellM, CastroN, VictorianoM, et al.An update of anthraquinone derivatives emodin, diacerein, and catenarin in diabetes. Evid Based Complement Alternat Med, 2021; 2021(1):3313419; doi: 10.1155/2021/3313419
11.
SongYP, FanX, GuoZ, et al.Therapeutic effects of emodin in type 2 diabetes mellitus in KKAy mouse model. Int J Clin Exp Med, 2017; 10(10):14408–14413.
12.
PatelAV, ShahBN. Transdermal drug delivery system: A review. Pharma Science Monitor, 2018; 9(1).
13.
JeongWY, KwonM, ChoiHE, et al.Recent advances in transdermal drug delivery systems: A review. Biomater Res, 2021; 25(1):24–25; doi: 10.1186/s40824-021-00226-6
14.
SabbaghF, KimBS. Recent advances in polymeric transdermal drug delivery systems. J Control Release, 2022; 341:132–146; doi: 10.1016/j.jconrel.2021.11.025
15.
TanwarH, SachdevaR. Transdermal drug delivery system: A review. International Journal of Pharmaceutical Sciences and Research, 2016; 7(6):2274; doi: 10.13040/IJPSR.0975-8232.7(6
16.
NgLC, GuptaM. Transdermal drug delivery systems in diabetes management: A review. Asian J Pharm Sci, 2020; 15(1):13–25; doi: 10.1016/j.ajps.2019.04.006
17.
HendradiE, MaharaniE, WahdahK, et al.The Effect of Sodium Alginate, Hydroxy Propyl Methyl Cellulose E15 and Ethyl Cellulose N22 as Polymeric Matrices on the Physicochemical Characteristics of Meloxicam Patch. In Proceedings of International Conference on Applied Pharmaceutical Sciences (ICoAPS). 2018 Oct 1.
18.
SchaferN, BalwierzR, BiernatP, et al.Natural ingredients of transdermal drug delivery systems as permeation enhancers of active substances through the stratum corneum. Mol Pharm, 2023; 20(7):3278–3297; doi: 10.1021/acs.molpharmaceut.3c00126
19.
XuQ, WuY, SaitoH, et al.Promoting activity of terpenes on skin permeation of famotidine. Chem Pharm Bull (Tokyo), 2023; 71(2):111–119; doi: 10.1248/cpb.c22-00568
20.
GuptaR, DwadasiBS, RaiB, et al.Effect of chemical permeation enhancers on skin permeability: In silico screening using molecular dynamics simulations. Sci Rep, 2019; 9(1):1456; doi: 10.1038/s41598-018-37900-0
21.
KriplaniP, SharmaA, AmanPP, et al.Formulation and evaluation of transdermal patch of diclofenac sodium. GJPPS, 2018; 4(5):1–4; doi: 10.19080/GJPPS.2018.04.555647
22.
SharmaD, AliAA, TrivediLR. An updated review on: Liposomes as drug delivery system. PT, 2018; 6(2):50–62; doi: 10.29161/PT.v6.i2.2018.50
23.
BudhathokiU, GartoullaK, ShakyaS. Formulation and evaluation of transdermal patches of atenolol. Indonesian J Pharm, 2016; 27(4):196; doi: 10.14499/indonesianjpharm27iss4pp196
24.
KulkarniS. Formulation and evaluation of transdermal patch for atomoxetine hydrochloride. J. Drug Deliv. Ther, 2019; 9:32–35.
25.
FoxLT, GerberM, PlessisJD, et al.Transdermal drug delivery enhancement by compounds of natural origin. Molecules, 2011; 16(12):10507–10540; doi: 10.3390/molecules161210507
26.
SrilakshmiA, TejaVR, LakshmiK, et al.Formulation and evaluation of transdermal patches of Irbesartan. Indian J Res in Pharmacy and Biotech, 2017; 5(3):212–215.
27.
RaiA, SharmaR, DewanganHK. Formulation and evaluation of polymeric transdermal patch of meloxicam. Materials Today: Proceedings, 2022; 68:803–808; doi: 10.1016/j.matpr.2022.06.156
28.
CherukuriS, BatchuUR, MandavaK, et al.Formulation and evaluation of transdermal drug delivery of topiramate. Int J Pharm Investig, 2017; 7(1):10–17; doi: 10.4103/jphi.JPHI_35_16
29.
DasA, AhmedAB. Formulation and evaluation of transdermal patch of indomethacin containing patchouli oil as natural penetration enhancer. Asian J Pharm Clin Res, 2017; 10(11):320–325; doi: 10.22159/ajpcr.2017.v10i11.20926
30.
ShivalingamMR, BalasubramanianAR, RamalingamKO. Formulation and evaluation of transdermal patches of pantoprazole sodium. Int J App Pharm, 2021; 31(5):287–291; doi: 10.22159/ijap.2021v13i5.42175
31.
ShehataTM, MohafezO, HaniehHN. Pharmaceutical formulation and biochemical evaluation of atorvastatin transdermal patches. IJPER, 2018; 52(1):54–61; doi: 10.5530/ijper.52.1.6
32.
CastañedaPS, Escobar-ChávezJJ, AguadoAT, et al.Design and evaluation of a transdermal patch with atorvastatin. Farmacia, 2017; 65(6):908–916.
33.
SinghA, BaliA. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. J Anal Sci Technol, 2016; 7(1):1–3; doi: 10.1186/s40543-016-0105-6
34.
GantiSS, BhattaccharjeeSA, MurnaneKS, et al.Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch. Int J Pharm, 2018; 550(1–2):71–78; doi: 10.1016/j.ijpharm.2018.08.033
35.
NoothiS, MalothuN, PulavarthyV, et al.Development of nanosponge formulations of rosuvastatin for oral delivery using a central composite design. Ind J Pharm Edu Res, 2024; 58(3):784–793.
36.
KriplaniP, GuarveK, BaghelUS. Formulation optimization and characterization of transdermal film of curcumin by response surface methodology. Chin Herb Med, 2021; 13(2):274–285; doi: 10.1016/j.chmed.2020.12.001
37.
DeviS, KaurN, KumarM, et al.In vitro and in vivo evaluation of antidiabetic potential and drug-herb interactions of Euphorbia neriifolia in streptozotocin-induced diabetes in rats and it’s in vitro antioxidant studies. Food Chemistry Advances, 2023; 2:100199; doi: 10.1016/j.focha.2023.100199
38.
Melesie TayeG, BuleM, Alemayehu GadisaD, et al.In vivo antidiabetic activity evaluation of aqueous and 80% methanolic extracts of leaves of Thymus schimperi (Lamiaceae) in alloxan-induced diabetic mice. Diabetes Metab Syndr Obes, 2020; 13:3205–3212; doi: 10.2147/DMSO.S268689
39.
VanLV, PhamEC, NguyenCV, et al.In vitro and in vivo antidiabetic activity, isolation of flavonoids, and in silico molecular docking of stem extract of Merremia tridentata (L.). Biomed Pharmacother, 2022; 146:112611; doi: 10.1016/j.biopha.2021.112611
40.
AlhassoB, GhoriMU, ConwayBR. Systematic review on the effectiveness of essential and carrier oils as skin penetration enhancers in pharmaceutical formulations. Sci Pharm, 2022; 90(1):14.
41.
HermanA, HermanAP. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: A review. J Pharm Pharmacol, 2015; 67(4):473–485; doi: 10.1111/jphp.12334
42.
KumarB, PandeyM, AggarwalR, et al.A comprehensive review on invasomal carriers incorporating natural terpenes for augmented transdermal delivery. Futur J Pharm Sci, 2022; 8(1):50.
43.
ZyburtowiczK, BednarczykP, NowakA, et al.Medicinal anti-inflammatory patch loaded with lavender essential oil. Int J Mol Sci, 2024; 25(11):6171.
44.
SaleemMN, IdrisM. Formulation design and development of a unani transdermal patch for antiemetic therapy and its pharmaceutical evaluation. Scientifica (Cairo), 2016; 2016(1):7602347; doi: 10.1155/2016/7602347
45.
YadavAV, UradeMN. Formulation and evaluation of chitosan based transdermal patches of lornoxicam for prolonged drug release and to study the effect of permeation enhancer. IJPER, 2019; 53(1):88–96; doi: 10.5530/ijper.53.1.12
46.
SuksaereeJ, SiripornpinyoP, ChaiprasitS. Formulation, characterization, and in vitro evaluation of transdermal patches for inhibiting crystallization of mefenamic acid. J Drug Deliv, 2017; 2017(1):7358042; doi: 10.1155/2017/7358042
47.
HardainiyanSW, KumarKR, NandyBC, et al.Design, formulation and in vitro drug release from transdermal patches containing imipramine hydrochloride as model drug. Int J Pharm Pharm Sci, 2017; 9(6):220; doi: 10.22159/ijpps.2017v9i6.16851
48.
HasanA, FarooquiH. A review on role of essential oil as penetration enhancer in transdermal drug delivery system. Syst. Rev. Pharm, 2021; 12:439–444.
49.
RavulaR, HerwadkarAK, AblaMJ, et al.Formulation optimization of a drug in adhesive transdermal analgesic patch. Drug Dev Ind Pharm, 2016; 42(6):862–870; doi: 10.3109/03639045.2015.1071832
50.
HashmatD, ShoaibMH, AliFR, SiddiquiF. Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers. PLoS One, 2020; 15(2):e0228908; doi: 10.1371/journal.pone.0228908
51.
KanjaniB, RaiG, GilhotraR, et al.Formulation design, optimization, and characterization of herbal bioactive-loaded transdermal patch: The state of the art. SGVU J. Pharm. Res. Educ, 2018; 3:279–288.
52.
WangH, LiY, WangC, et al.The enhancing effect and promoting mechanisms of the stereoisomeric monoterpene alcohol esters as enhancers for drugs with different physicochemical properties. Asian J Pharm Sci, 2022; 17(1):139–152; doi: 10.1016/j.ajps.2021.11.003
53.
SugumarV, HayyanM, MadhavanP, et al.Current development of chemical penetration enhancers for transdermal insulin delivery. Biomedicines, 2023; 11(3):664.
